Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.37 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | NQO2 | P16083 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | HTR2A | P28223 | 1/20 | 0.36 |
| ▸ | HTR2C | P28335 | 1/20 | 0.36 |
| ▸ | ERCC1 | P07992 | 1/20 | 0.35 |
| ▸ | FEN1 | P39748 | 1/20 | 0.35 |
| ▸ | ERCC4 | Q92889 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23874998 | 0.91 | GPR3 (0.45) | GPR3KDM4EMAPTTSHRALKBH5 | |
| SCHEMBL18626366 | 0.90 | GPR3 (0.44) | GPR3KDM4EMAPTTSHRALKBH5 | |
| SCHEMBL23625525 | 0.82 | GPR3 (0.47) | GPR3KDM4EMAPTTSHRALKBH5 | |
| SCHEMBL22352479 | 0.78 | GPR3 (0.31) | GPR3 | |
| SCHEMBL20857465 | 0.78 | GPR3 (0.31) | GPR3 | |
| SCHEMBL14233356 | 0.76 | L3MBTL1 (0.50) | KDM4EMAPTCYP2C19CYP1A2ALDH1A1 | |
| SCHEMBL18746036 | 0.76 | GPR3 (0.52) | GPR3KDM4EMAPTALKBH5FTO | |
| SCHEMBL21578607 | 0.75 | GPR3 (0.31) | GPR3 | |
| SCHEMBL19774619 | 0.75 | GPR3 (0.31) | GPR3 | |
| SCHEMBL16870944 | 0.75 | GPR3 (0.31) | GPR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4289855-A1 | METHOD FOR PREPARING PHOSPHORUS-CONTAINING LIGAND | Zhejiang NHU Company Ltd. (CN) | 2023-12-13 | — | — | EP | disclosed |
| US-20230303537-A1 | NITROGEN-CONTAINING COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE THEREOF | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-09-28 | — | — | US | disclosed |
| US-20230209992-A1 | ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME | LG DISPLAY CO., LTD. (KR) | 2023-06-29 | — | — | US | disclosed |
| US-20230203239-A1 | Cyclic ether-anhydride photopolyaddition and uses thereof | UNIVERSITÉ DE HAUTE-ALSACE (FR) | 2023-06-29 | — | — | US | disclosed |
| US-20220109115-A1 | POLYCYCLIC COMPOUND, AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE POLYCYCLIC COMPOUND | IDEMITSU KOSAN CO.,LTD. (JP) | 2022-04-07 | — | — | US | disclosed |
| US-20210363286-A1 | Ultrafast Cyclic Ether-Amine Photopolyaddition And Uses Thereof | UNIVERSITÉ DE HAUTE-ALSACE (FR) | 2021-11-25 | — | — | US | disclosed |
| EP-3909946-A2 | ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | Samsung Display Co., Ltd. (KR) | 2021-11-17 | — | — | EP | disclosed |
| US-9624171-B2 | Photoinitiator mixtures | BASF SE (DE) | 2017-04-18 | — | — | US | disclosed |
| US-20170098781-A1 | NEW DIBENZOFURANS AND DIBENZOTHIOPHENES | IDEMITSU KOSAN CO., LTD. (JP) | 2017-04-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220109115-A1 | POLYCYCLIC COMPOUND, AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE POLYCYCLIC COMPOUND | ODC1, OTC, PKD1 | GPR3 3959/4885KDM4E 2871/4885MAPT 3163/4885 |
| US-20170098781-A1 | NEW DIBENZOFURANS AND DIBENZOTHIOPHENES | DBF4, DDT, SLC43A3 | GPR3 4658/4885KDM4E 2610/4885MAPT 2086/4885 |
| US-20230303537-A1 | NITROGEN-CONTAINING COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE THEREOF | NPM1, NFE2L2, MNS1 | GPR3 4534/4885KDM4E 2222/4885MAPT 2129/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.